NCT02068456View on ClinicalTrials.gov

Post Marketing Surveillance of Roflumilast in Korea

CompletedOBSERVATIONAL

Enrollment

1,837

Participants

Timeline

Start Date

September 18, 2012

Primary Completion Date

April 26, 2017

Study Completion Date

April 26, 2017

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Roflumilast

Trial Locations (1)

Unknown

Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY